Themis Bioscience
A biotechnology company developing immune-modulation therapies for infectious diseases and cancer leveraging its technology platform and understanding of immune system mechanisms. It was founded in 2009 and is located in Vienna, Austria.
3
Funding Rounds
$68.0m
Money raised
Overview
A biotechnology company developing immune-modulation therapies for infectious diseases and cancer leveraging its technology platform and understanding of immune system mechanisms. It was founded in 2009 and is located in Vienna, Austria.
| Name | Phone | Social networks | |
|---|---|---|---|
| Dr* Er*** Ta**** | - | - | - |
Funding series
Funding Series Analysis
The company Themis Bioscience has raised a total of $12m in funding over 3 rounds.
Key Insights:
- Themis Bioscience Series C round, January 2017: $12m
- Themis funding round, January 2018: $12m
- Themis Bioscience funding round, September 2019: $44m
Themis Bioscience Series C round, January 2017
$12m
Themis funding round, January 2018
$12m
Themis Bioscience funding round, September 2019
$44m
Industries
Themis Bioscience is active in the following industries:
- Manufacturing
- Healthcare
- Biotechnology
- Research and development
- Drug discovery
- Biology
- Technology
- Vaccine